Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CLAUDIO MILITE

NPI
1396761458
CMS profile
290450
Location
VERNON, CT

General Payments · PY2018–2024

$2,780.42

  • Reported across 143 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$790.35

38 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $712.53 34
Education $77.82 4

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $325.87 22
PY2019 $460.64 25
PY2020 $115.19 6
PY2021 $749.20 33
PY2022 $206.19 13
PY2023 $132.98 6
PY2024 $790.35 38

Payment records · PY2024 (38)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AKEBIA THERAPEUTICS INC $28.71 06/04/2024 Food and Beverage Undisputed 01/23/2026 1145825681 CMS
Amgen Inc. $13.08 03/28/2024 Food and Beverage Undisputed 01/23/2026 1117328452 CMS
Amgen Inc. $13.08 03/28/2024 Food and Beverage Undisputed 01/23/2026 1117328454 CMS
Amgen Inc. $25.14 05/22/2024 Food and Beverage Undisputed 01/23/2026 1111652191 CMS
Amgen Inc. $26.14 08/29/2024 Food and Beverage Undisputed 01/23/2026 1111652193 CMS
Ardelyx, Inc. $21.09 01/11/2024 Food and Beverage Undisputed 01/23/2026 1146695742 CMS
Ardelyx, Inc. $26.03 04/02/2024 Food and Beverage Undisputed 01/23/2026 1146695744 CMS
Ardelyx, Inc. $23.04 07/15/2024 Food and Beverage Undisputed 01/23/2026 1146695746 CMS
AstraZeneca Pharmaceuticals LP $27.62 01/16/2024 Food and Beverage Undisputed 01/23/2026 1110546351 CMS
AstraZeneca Pharmaceuticals LP $25.89 04/30/2024 Food and Beverage Undisputed 01/23/2026 1110545709 CMS
AstraZeneca Pharmaceuticals LP $20.15 10/23/2024 Food and Beverage Undisputed 01/23/2026 1110537917 CMS
Aurinia Pharma U.S., Inc. $19.73 07/02/2024 Food and Beverage Undisputed 01/23/2026 1150687553 CMS
Baxter Healthcare $18.83 08/20/2024 Food and Beverage Undisputed 01/23/2026 1118298750 CMS
Bayer Healthcare Pharmaceuticals Inc. $15.36 04/16/2024 Food and Beverage Undisputed 01/23/2026 1086134442 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.07 06/18/2024 Food and Beverage Undisputed 01/23/2026 1117993800 CMS
CorMedix Inc. $13.73 11/27/2024 Food and Beverage Undisputed 01/23/2026 1082026399 CMS
Fresenius USA Marketing, Inc. $21.03 05/16/2024 Food and Beverage Undisputed 01/23/2026 1154204454 CMS
Fresenius USA Marketing, Inc. $24.13 10/08/2024 Food and Beverage Undisputed 01/23/2026 1154204456 CMS
Fresenius USA Marketing, Inc. $24.17 12/10/2024 Food and Beverage Undisputed 01/23/2026 1154204458 CMS
Lilly USA, LLC $20.69 01/02/2024 Food and Beverage Undisputed 01/23/2026 1136099856 CMS
Lilly USA, LLC $22.11 04/03/2024 Food and Beverage Undisputed 01/23/2026 1136103876 CMS
Lilly USA, LLC $14.18 12/16/2024 Food and Beverage Undisputed 01/23/2026 1136128261 CMS
Mallinckrodt Hospital Products Inc. $26.00 07/30/2024 Food and Beverage Undisputed 01/23/2026 1145107796 CMS
Mallinckrodt Hospital Products Inc. $19.59 09/17/2024 Food and Beverage Undisputed 01/23/2026 1145107800 CMS
Novartis Pharmaceuticals Corporation $33.10 08/27/2024 Food and Beverage Undisputed 01/23/2026 1087116218 CMS
Novo Nordisk Inc $32.27 09/24/2024 Education Undisputed 01/23/2026 1108574560 CMS
Novo Nordisk Inc $15.43 09/24/2024 Food and Beverage Undisputed 01/23/2026 1108579411 CMS
Novo Nordisk Inc $21.45 11/12/2024 Food and Beverage Undisputed 01/23/2026 1108575818 CMS
Otsuka America Pharmaceutical, Inc. $16.64 04/26/2024 Food and Beverage Undisputed 01/23/2026 1118942907 CMS
Otsuka America Pharmaceutical, Inc. $16.99 10/17/2024 Food and Beverage Undisputed 01/23/2026 1118942909 CMS
Otsuka America Pharmaceutical, Inc. $13.21 11/25/2024 Food and Beverage Undisputed 01/23/2026 1118942911 CMS
Travere Therapeutics, Inc. $16.89 01/25/2024 Education Undisputed 01/23/2026 1149895553 CMS
Travere Therapeutics, Inc. $19.53 01/25/2024 Food and Beverage Undisputed 01/23/2026 1149895565 CMS
Travere Therapeutics, Inc. $18.24 05/07/2024 Food and Beverage Undisputed 01/23/2026 1149895561 CMS
Travere Therapeutics, Inc. $26.78 06/06/2024 Food and Beverage Undisputed 01/23/2026 1149895573 CMS
Travere Therapeutics, Inc. $24.57 07/25/2024 Food and Beverage Undisputed 01/23/2026 1149895569 CMS
Travere Therapeutics, Inc. $11.77 09/25/2024 Education Undisputed 01/23/2026 1149895549 CMS
Travere Therapeutics, Inc. $16.89 09/25/2024 Education Undisputed 01/23/2026 1149895557 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.